Your session is about to expire
← Back to Search
Antibiotic
Preoperative Antibiotics for Dental Implant Failure
Phase 1
Recruiting
Led By Robert Durand, DMD, MS
Research Sponsored by Université de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 4 months, 1 year
Awards & highlights
Summary
This trial will study the effect of preoperative azithromycin on implant surgery outcomes. It is a double-masked, placebo-controlled, randomized clinical trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week, 4 months, 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 4 months, 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
peri-implant crestal bone change
Secondary outcome measures
anxiety
bleeding index
duration of surgery (minutes)
+19 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: TestActive Control1 Intervention
- 500mg of azithromycin one hour before implant placement
Group II: controlPlacebo Group1 Intervention
- identical placebo one hour before implant placement
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Centre de Recherche du Centre Hospitalier de l'Université de MontréalOTHER
52 Previous Clinical Trials
94,277 Total Patients Enrolled
Université de MontréalLead Sponsor
218 Previous Clinical Trials
103,048 Total Patients Enrolled
Robert Durand, DMD, MSPrincipal InvestigatorUniversité de Montréal
1 Previous Clinical Trials
42 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a site on your body that is not infected.You have enough bone and soft tissue in the area where the implant will be placed, without needing additional procedures to add more bone.You are regularly taking pain relievers or medications for depression.You use marijuana.You have no teeth.You have dental implants that are 6 millimeters or longer.You have severe gum disease or bad oral hygiene.You have a history of using drugs in ways that are harmful or illegal.You currently have or are at risk of developing stomach ulcers.You have a weakened immune system, either throughout your body or in a specific area.You currently have a severe infection in your mouth.You have uncontrolled diabetes or other serious health conditions.You are currently receiving intravenous bisphosphonates.You have been taking oral bisphosphonates for more than 4 years.You have been taking corticosteroids for a long time.You smoke at least 10 cigarettes or cigars every day.You are not allowed to use vaping devices or e-cigarettes during the study.You are allergic to macrolides (a type of antibiotic) or non-steroidal anti-inflammatory drugs (pain relievers).You have missing teeth and need to replace them with a maximum of 2 dental implants.
Research Study Groups:
This trial has the following groups:- Group 1: Test
- Group 2: control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger